Gardner Lewis Asset Management L P Insmed Inc Transaction History

Gardner Lewis Asset Management L P

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 14, 2020	SELL	$16.12 - $24.98 $1.23 Million - $1.9 Million	-76,105 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$15.49 - $25.78 $481,816 - $801,886	-31,105 Reduced 29.01%	76,105 $1.34 Million
Q2 2019 Aug 14, 2019	BUY	$23.0 - $32.19 $882,280 - $1.23 Million	38,360 Added 55.72%	107,210 $2.75 Million
Q1 2019 May 15, 2019	BUY	$13.91 - $31.15 $957,703 - $2.14 Million	68,850 New	68,850 $2 Million

484

182M

2.14M

3.25M

Ticker INSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 135,476,992
Market Cap $10.6B
Description
Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...

Get notified when there are updates to the investment portfolio of Gardner Lewis Asset Management L P, based on Form 13F filings with the SEC.

Stay updated on Gardner Lewis Asset Management L P with notifications on news.